GOSS: Gossamer Bio Inc Kompaniya qiymatining sof foydaga nisbati
Gossamer Bio, Inc. (GOSS) uchun xavflar premium nishani egallashda gipertoniyaga qarshi dori vositalarining muvaffaqiyatiga bog'liqligi bilan bog'liq. Kompaniyaning P/E koeffitsiyenti o'zgarishlari barqarorlik ko'rsatkichi vazifasini o'taydi, bunda -0.50 oxirgi metrika qiymatini ifodalaydi. Vaziyat rahbarlarning hamkorlarni jalb qilishdagi tajribasi va o'pka loyihalarining joriy strategik moslashtiruvi bilan muvozanatlashgan bo'lib, bu esa investorlarning me'yorda optimizmini oshirmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_GOSS_-_Gossamer-Bio-Inc._-_PE-Multiple "GOSS: Gossamer Bio, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Gossamer Corp (GOSS) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Gossamer Bio, Inc.|GOSS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Gossamer Bio Corp.|GOSS - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Gossamer Bio, Inc.|GOSS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Gossamer Bio|Kritik likvidlik gossamerbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
GOSS - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Gossamer Bio, Inc.|GOSS - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Gossamer Bio Inc|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Gossamer Bio, Inc.|GOSS - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Gossamer Bio|GOSS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi gossamerbio.com|GOSS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Gossamer Bio, Inc.
Kompaniyaning har tomonlama tahlili:gossamerbio.com GOSS
P/E koeffitsiyenti foydaning bir birligi qiymatini belgilaydi, bu esa investorga bozor kapitalizatsiyasining sof foydaga nisbati orqali aktivning haddan tashqari sotib olingan holatini va investitsiyalarning qoplanish muddatini baholash imkonini beradi. Gossamer Bio, Inc. (GOSS) kompaniyasining joriy P/E koeffitsiyentini tahlil qilish orqali kelajakdagi patentlar narxga kiritilgan yoki kiritilmaganini aniqlash mumkin, chunki kompaniyaning biznes modeli terapiyasining keyingi global kengayishiga erishish uchun ulkan R&D xarajatlarini nazarda tutadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Tourmaline (TRML)|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Upstream Bio, Inc. (UPB) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Biznesning o‘zini qoplash muddati Immunome Bio|P/E multiplikatori KALV (KalVista Pharmaceuticals)|P/E multiplikatori septerna.com SEPN|PVLA - Narxning foydaga nisbati|Savara Inc (SVRA) - Narx-foyda koeffitsiyenti|RIGL: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati AnaptysBio Inc. (ANAB)|Narxning foydaga nisbati Astria Therapeutics|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris)|Kyverna Therapeutics, Inc - Narxning foydaga nisbati|Tiziana Life Sciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati cabalettabio.com CABA|Ventyx Biosciences, Inc. (VTYX) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Theratechnologies, Inc. (THTX)|Narx-foyda koeffitsiyenti AVTX|ELDN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AGEN|Biznesning o‘zini qoplash muddati climbbio.com|Narxning foydaga nisbati Zura Bio ZURA|ATYR: Narx-foyda multiplikatori|Adagene Corp - P/E multiplikatori|ImageneBio Inc (IMA) - Narx-foyda koeffitsiyenti|STTK (shattucklabs.com) - Narx-foyda koeffitsiyenti|EQ - Biznesning o‘zini qoplash muddati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|IMUX - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|Biznesning o‘zini qoplash muddati Adicet Bio Inc. (ACET)|CELU - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati INmune Bio Inc INMB|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences Inc)|SABS (SAB Biotherapeutics) - P/E multiplikatori|AKTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|Narxning foydaga nisbati GeoVax Labs Inc GOVX|Kompaniya qiymatining sof foydaga nisbati EDSA|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|Narx-foyda koeffitsiyenti HCWB|APVO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AIM|Biznesning o‘zini qoplash muddati aditxt.com|Narxning foydaga nisbati GRI Bio GRI|XRTX - Narx-foyda koeffitsiyenti|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|scinai.com (SCNI) - P/E multiplikatori|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|P/E multiplikatori ALLK|HOOK - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti iteostherapeutics.com|OCEA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
